Summary

Intec Pharma ltd. (Intec Pharma) is a drug development company. The company develops and markets improved formulations of existing drugs. It offers products that include Carbidopa / Levodopa GR, Zaleplon GR, and Baclofen GR. Its Levodopa GR is a drug used for the symptomatic therapy of Parkinson's disease; and Zaleplon GR is used for the treatment of Insomnia. Intec Pharma offers products for various therapeutic areas, including the central nervous system, the cardiovascular system, and gastrointestinal and infectious diseases. The company provides innovative proprietary gastric retention technology to develop improved formulations of existing drugs. It has collaborations with multi-national pharmaceutical companies. Intec Pharma is headquartered in Jerusalem, Israel.

Intec Pharma ltd. Key Recent Developments

Jul 10, 2014: Mr. Carni is discontinuing as Co-CEO, Mr. Weiss will continue to reign as the sole CEO
Jun 06, 2012: Intec Pharma Opens New Production Line To Produce Accordion Pills

This comprehensive SWOT profile of Intec Pharma ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including*,



- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table Of Contents

Table of Contents

Section 1 - About the Company

Intec Pharma ltd. - Key Information
Intec Pharma ltd. - Overview
Intec Pharma ltd. - Key Employees
Intec Pharma ltd. - Key Employee Biographies
Intec Pharma ltd. - Key Operational Heads
Intec Pharma ltd. - Major Products and Services
Intec Pharma ltd. - History
Intec Pharma ltd. - Company Statement
Intec Pharma ltd. - Locations And Subsidiaries
Intec Pharma ltd. - Key Manufacturing facilities
Head Office
Other Locations and Subsidiaries

Section 2 - Company Analysis

Intec Pharma ltd. - Business Description
Intec Pharma ltd. - Corporate Strategy
Intec Pharma ltd. - SWOT Analysis
SWOT Analysis - Overview
Intec Pharma ltd. - Strengths
Intec Pharma ltd. - Weaknesses
Intec Pharma ltd. - Opportunities
Intec Pharma ltd. - Threats
Intec Pharma ltd. - Key Competitors

Section 3 - Company Financial Performance Charts

Intec Pharma ltd. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intec Pharma ltd., Key Information
Intec Pharma ltd., Key Ratios
Intec Pharma ltd., Share Data
Intec Pharma ltd., Major Products and Services
Intec Pharma ltd., History
Intec Pharma ltd., Key Employees
Intec Pharma ltd., Key Employee Biographies
Intec Pharma ltd., Key Operational Heads
Intec Pharma ltd., Other Locations
Intec Pharma ltd., Subsidiaries
Intec Pharma ltd., Key Manufacturing facilities
Intec Pharma ltd., Key Competitors
Intec Pharma ltd., SWOT Analysis
Intec Pharma ltd., Ratios based on current share price
Intec Pharma ltd., Annual Ratios
Intec Pharma ltd., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Tables

Intec Pharma ltd., Performance Chart
Intec Pharma ltd., Ratio Charts

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Drug Discovery and Development in United States: Omeros Corporation – Product Pipeline Review – H2 2011

Drug Discovery and Development in United States: Omeros Corporation – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

Pharmaceutical in Japan: Astellas Pharma Inc. – Product Pipeline Review – H2 2011

Pharmaceutical in Japan: Astellas Pharma Inc. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the Astellas Pharma Inc.’s research and development focus. The report includes data on current developmental pipeline, complete ...

Pathology in United States: Boehringer Ingelheim GmbH – Product Pipeline Review – H2 2011

Pathology in United States: Boehringer Ingelheim GmbH – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...


5 Companies

Company Profiles

Evotec AG

Germany

Eli Lilly and Co.

United States

Genentech Inc.

United States

Gilead Sciences Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.